Diabetes Mellitus Flashcards
Insulin
Polypeptide containing 2 peptide chains that are linked by disulfide bridges
Glucagon-like Peptide
derived from proglucagon in the L-cells of the intestinal mucosa, which is cleaved to produce GLP-1 and GLP-2, not glucagon.
GLP-1 strongly augments glucose-stimulated insulin release, decreases glucagon secretion, and inhibits gastric motility and acid secretion
Glucagon
Produced by alpha cells of the isltes and released by vagal stimulation.
Glucagon directly stimulates insulin release.
Raise blood glucose levels by activation of hepatic gluconeogenesis and accelerated glycogenolysis.
Inhibited by insulin and somatostatin
Somatostatin
inhibitory peptide.
Released from delta cells, inhibits glucagon and insulin release.
inhibits voltage dependent calcium channels.
Miscellaneous Peptide
Gastric Inhibitory Peptide (GIP), vasoactive intestinal peptide,
Physiologic Action of Insulin
Facilitates the entry of glucose into cells by increasing the number of glucose transporters in the cell membrane. The only cells that do not need insulin for glucose uptake are liver, red blood cells, and brain.
Increases uptake of amino acids and potassium inot insulin-sensitive cells
Stimulates protein synthesis
Inhibits protein degradation
Activates glycogen synthetase and glycolytic enzymes
Inhibits phophorylase and gluconeogenic enzymes
Incrases mRNAs for lipogenic enzymes, which promotes lipogenesis
Inhibits Hormone-sensitive lipase, which inhibits lypolysis
Canine Diabetes
Type 1 Human Diabetes mellitus (Insulin dependent diabetes mellitus)
Insulin Deficient
NO change in serum insulin level after glucagon or glucose challenge test.
Dogs require insulin to control hyperglycemia form the time of DM diagnosis
Prone to develop Ketosis as a result of isulin deficiency and a proportion of cases present in a state of diabetic Ketoacidosis
Feline Diabetes
Type 2 Human DM
Insulin resistance and a relative insulin deficiency are pathological characteristics of human Type 2 DM.
Plasma insulin level may actually be increased, but not enought o control hyperglycemia
Obese cats have insulin Resistance, abnormal insulin secretory response to glucose challenges, and increased islet amylin depostition but the natural progession form obese non-diabetic to diabetic is not well documented.
Transient Diabetes Mellitus or “DM remission”
20% of cats diagnosed with diabetes mellitus
Term misnomer since it is actually the insulin requirement that resolves in these cats, while the underlying pathology that led to the development of clinically diabetic may persist.
Miscellaneous causes of diabetes in dogs and cats
can result form pathologies that are uncommon and distinct form the etiologies of typical diabetes as discussed above
Juvenile Diabetes
Uncommon but occasionally encountered in puppies and kittens.
Potential causes include any variety of congenital pancreatic anomalies
Secondary Diabetes mellitus
Can develop secondary to another pathology
Pancreatitis, pancreatic neoplasia.
Hyperadrenocorticism and acromegaly.
Administration of Glucocorticoids and progestin compounds
Gestational Diabetes
Precipitated by physiologic changes that occur during pregnancy has been reported in small numbers of dogs in scandinavia.
Diabetes Mellitius
Chronic syndrome of impaired carbohydrate, protein, and fat metabolism due to relative or absolute deficiency of insulin secretion
Ketoacidosis
Acidosis caused by the accumulation of ketone compounds
Three important ketones are:
acetone
acetoacetic acid
beta-hydroxybutyric acid
Glucosuria
Presence of glucose in the urine
Glucose appears in the urine only after the renal threshold for glucose reabsorption is exceeded.
Renal threshold is 180-220 mg/dL (dog) and 260-280mg/dL (cat)
Criteria needed to make diagnosis of DM
Appropriate clinical sings
Persistent hyperglycemia
Glycosuria
Diagnostic Work-up
CBC
Serum biochemistry profile
Urinalysis
Urine culture
Serum Fructosamine or hemoglobin A1c test